143 related articles for article (PubMed ID: 6744246)
41. Effect of coadministration of phenobarbital sodium on N-nitrosodiethylamine-induced gamma-glutamyltransferase-positive foci and hepatocellular carcinoma in rats.
Pereira MA; Herren-Freund SL; Britt AL; Khoury MM
J Natl Cancer Inst; 1984 Mar; 72(3):741-4. PubMed ID: 6142138
[TBL] [Abstract][Full Text] [Related]
42. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
Moser GJ; Wolf DC; Goldsworthy TL
Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259
[TBL] [Abstract][Full Text] [Related]
43. 1alpha, 25-dihydroxyvitamin D3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital.
Banakar MC; Paramasivan SK; Chattopadhyay MB; Datta S; Chakraborty P; Chatterjee M; Kannan K; Thygarajan E
World J Gastroenterol; 2004 May; 10(9):1268-75. PubMed ID: 15112340
[TBL] [Abstract][Full Text] [Related]
44. Promotion of malignant 'embryonal' liver tumors by phenobarbital: increased incidence and shortened latency of hepatoblastomas in (DBA/2 x C57BL/6)F1 mice initiated with N-nitrosodiethylamine.
Diwan BA; Ward JM; Rice JM
Carcinogenesis; 1989 Jul; 10(7):1345-8. PubMed ID: 2472233
[TBL] [Abstract][Full Text] [Related]
45. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats.
Tanaka T; Kojima T; Kawamori T; Yoshimi N; Mori H
Cancer Res; 1993 Jun; 53(12):2775-9. PubMed ID: 8504418
[TBL] [Abstract][Full Text] [Related]
46. Effect of Solanum trilobatum on the antioxidant status during diethyl nitrosamine induced and phenobarbital promoted hepatocarcinogenesis in rat.
Shahjahan M; Vani G; Shyamaladevi CS
Chem Biol Interact; 2005 Oct; 156(2-3):113-23. PubMed ID: 16188247
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice.
Mirsalis JC; Shimon JA; Johnson A; Fairchild D; Kanazawa N; Nguyen T; de Boer J; Glickman B; Winegar RA
Environ Mol Mutagen; 2005; 45(1):17-35. PubMed ID: 15605353
[TBL] [Abstract][Full Text] [Related]
48. Chemo-preventive effect of Star anise in N-nitrosodiethylamine initiated and phenobarbital promoted hepato-carcinogenesis.
Yadav AS; Bhatnagar D
Chem Biol Interact; 2007 Sep; 169(3):207-14. PubMed ID: 17658503
[TBL] [Abstract][Full Text] [Related]
49. Sodium phenobarbital-enhanced mutation frequency in the liver DNA of lacZ transgenic mice treated with diethylnitrosamine.
Okada N; Honda A; Kawabata M; Yajima N
Mutagenesis; 1997 May; 12(3):179-84. PubMed ID: 9175645
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of tumor promotion and hepatocellular growth by dietary restriction in mice.
Kolaja KL; Bunting KA; Klaunig JE
Carcinogenesis; 1996 Aug; 17(8):1657-64. PubMed ID: 8761422
[TBL] [Abstract][Full Text] [Related]
51. Soybean isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by phenobarbital in female rat liver.
Lee KW; Wang HJ; Murphy PA; Hendrich S
Nutr Cancer; 1995; 24(3):267-78. PubMed ID: 8610046
[TBL] [Abstract][Full Text] [Related]
52. Suppressive effect of irsogladine maleate on diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis in male F344 rats.
Sugie S; Okamoto K; Ueda F; Watanabe T; Tanaka T; Mori H
Jpn J Cancer Res; 1998 Apr; 89(4):371-6. PubMed ID: 9617341
[TBL] [Abstract][Full Text] [Related]
53. Quantitation of the cancer process in C57BL/6J, B6C3F1 and C3H/HeJ mice.
Goldsworthy TL; Fransson-Steen R
Toxicol Pathol; 2002; 30(1):97-105. PubMed ID: 11890483
[TBL] [Abstract][Full Text] [Related]
54. Promoting effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in mouse hepatocarcinogenesis.
Dragani TA; Manenti G; Galliani G; Della Porta G
Carcinogenesis; 1985 Feb; 6(2):225-8. PubMed ID: 3971489
[TBL] [Abstract][Full Text] [Related]
55. Hepatocyte expression of tumor associated aldehyde dehydrogenase (ALDH-3) and p21 Ras following diethylnitrosamine (DEN) initiation and chronic exposure to di(2-ethylhexyl)phthalate (DHEP).
Richmond RE; Carter JH; Carter HW; Daniel FB; Deangelo AB
Carcinogenesis; 1996 Aug; 17(8):1647-55. PubMed ID: 8761421
[TBL] [Abstract][Full Text] [Related]
56. Decreased hepatocarcinogenic effect of diethylnitrosamine in experimentally induced liver cirrhosis in rat: delay or inhibition?
Zalatnai A; Lapis K
Cancer Lett; 1994 Apr; 79(1):1-7. PubMed ID: 8187048
[TBL] [Abstract][Full Text] [Related]
57. Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5- dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B.
Diwan BA; Henneman JR; Rice JM; Nims RW
Carcinogenesis; 1996 Jan; 17(1):37-43. PubMed ID: 8565134
[TBL] [Abstract][Full Text] [Related]
58. Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGF-alpha transgenic mice.
Puatanachokchai R; Kakuni M; Wanibuchi H; Kinoshita A; Kang JS; Salim EI; Morimura K; Tamano S; Merlino GT; Fukushima S
Asian Pac J Cancer Prev; 2006; 7(2):274-8. PubMed ID: 16839222
[TBL] [Abstract][Full Text] [Related]
59. β-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice.
Awuah PK; Rhieu BH; Singh S; Misse A; Monga SP
PLoS One; 2012; 7(6):e39771. PubMed ID: 22761897
[TBL] [Abstract][Full Text] [Related]
60. Promotion by sodium barbital of renal cortical and transitional cell tumors, but not intestinal tumors, in F344 rats given methyl(acetoxymethyl)nitrosamine, and lack of effect of phenobarbital, amobarbital, or barbituric acid on development of either renal or intestinal tumors.
Diwan BA; Ohshima M; Rice JM
Carcinogenesis; 1989 Jan; 10(1):183-8. PubMed ID: 2910521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
